Lilly COVID Antibody Trial Ends

A clinical trial involving an antibody treatment developed by Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has ended. The trial, sponsored by the National Institute of Allergy and Infectious Disea... Read More